Abstract C005: Exploratory biomarker evaluation of the randomized Phase 2 cohort of CM24 in combination with nivolumab and chemotherapy in advanced/metastatic pancreatic cancer
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Teresa Macarulla, Michael Cecchini, Rocio Garcia-Carbonero, Talia Golan, Ruth Perets, Erkut Borazanci, Manuel Pedegral, Mariano Ponz-Sarvisé, Mohammed Najeeb Al Hallak, Shubham Pant, Valentina Boni, Omar Saavedra, María José de Miguel-Luken, Alexis D. Leal, Andrés J. Muñoz Martín, Tamara Sauri-Nadal, Michael Schickler, Hava Ben David, Hadas Reuveni
Institutions: Vall d'Hebron Hospital Universitari, Yale University, Hospital Universitario 12 De Octubre, Sheba Medical Center, Rambam Health Care Campus, HonorHealth, Hospital Universitario Fundación Jiménez Díaz, Clinica Universidad de Navarra, The Barbara Ann Karmanos Cancer Institute, The University of Texas MD Anderson Cancer Center, Hospital Universitario Quirónsalud Madrid, Hospital Universitario HM Sanchinarro, University of Colorado Anschutz, Hospital General Universitario Gregorio Marañón, Hospital Clínic de Barcelona
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402551671